Correction to: CGRP induces migraine-like symptoms in mice during both the active and inactive phases
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1129-2377
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correction to: CGRP induces migraine-like symptoms in mice during both the active and inactive phases ; volume:22 ; number:1 ; day:5 ; month:10 ; year:2021 ; pages:1 ; date:12.2021
The journal of headache and pain ; 22, Heft 1 (5.10.2021), 1, 12.2021
- Creator
-
Wattiez, Anne-Sophie
Gaul, Olivia J.
Kuburas, Adisa
Zorrilla, Erik
Waite, Jayme S.
Mason, Bianca N.
Castonguay, William C.
Wang, Mengya
Robertson, Bennett R.
Russo, Andrew F.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s10194-021-01332-5
- URN
-
urn:nbn:de:101:1-2021122219010788423576
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wattiez, Anne-Sophie
- Gaul, Olivia J.
- Kuburas, Adisa
- Zorrilla, Erik
- Waite, Jayme S.
- Mason, Bianca N.
- Castonguay, William C.
- Wang, Mengya
- Robertson, Bennett R.
- Russo, Andrew F.
- SpringerLink (Online service)
Other Objects (12)
CGRP induces migraine-like symptoms in mice during both the active and inactive phases
CGRP and migraine: neurogenic inflammation revisited
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
CGRP-targeted medication in chronic migraine - systematic review
Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Serum CGRP in migraine patients using erenumab as preventive treatment
Shared and independent roles of CGRP and PACAP in migraine pathophysiology
“Triaging” Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies
CGRP in Childhood and Adolescence Migraine: (Patho)physiological and Clinical Aspects
CGRP induces migraine-like symptoms in mice during both the active and inactive phases
CGRP and migraine: neurogenic inflammation revisited
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
CGRP-targeted medication in chronic migraine - systematic review
Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Serum CGRP in migraine patients using erenumab as preventive treatment
Shared and independent roles of CGRP and PACAP in migraine pathophysiology
“Triaging” Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies
CGRP in Childhood and Adolescence Migraine: (Patho)physiological and Clinical Aspects
CGRP induces migraine-like symptoms in mice during both the active and inactive phases
CGRP and migraine: neurogenic inflammation revisited
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
CGRP-targeted medication in chronic migraine - systematic review
Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Serum CGRP in migraine patients using erenumab as preventive treatment
Shared and independent roles of CGRP and PACAP in migraine pathophysiology
“Triaging” Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies